Eolo Pharma
PrivateLast Round
Series A
Extension
Jul 15, 2022
Total Funding Raised
$5.7M
Company Overview
Eolo Pharma operates in Healthcare & Life Sciences and is based in Montevideo. Its latest recorded funding round was a Series A Extension round in July 2022.
Eolo Pharma is a clinical-stage biotechnology company developing novel small-molecule therapies for the treatment of obesity and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eolo Pharma Comparables
Compare Eolo Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Energesis Pharmaceuticals, Inc. | 86% | |
| Equator Therapeutics | 84% | |
| Rivus Pharmaceuticals | 84% |
For institutional investors. Book with your work email.
Eolo Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 15, 2022 | ||||
| Series A | Dec 31, 2019 | ||||
| Seed | Dec 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Eolo Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CITES | Series A, Series A Extension, Seed |
| Ficus Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 432% MoM, reaching 2.1K.
- Jul 15, 2022
$3M round led by Paul Elberse
For institutional investors. Book with your work email.
Eolo Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Eolo Pharma's valuation, stock price, and market status.
Is Eolo Pharma a public or private company?
Eolo Pharma is a private company.
What is the current stock price of Eolo Pharma?
Eolo Pharma is a private company, so its shares have no public market price. Caplight tracks Eolo Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eolo Pharma worth (valuation)?
Valuation information for Eolo Pharma is not publicly available.
Can I buy Eolo Pharma stock?
Eolo Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eolo Pharma's last funding round?
Eolo Pharma's most recent funding round was Series A Extension on July 15, 2022.
Who are the main investors in Eolo Pharma?
Key investors in Eolo Pharma include Ficus Capital.
Will Eolo Pharma IPO soon?
No public IPO plans have been announced for Eolo Pharma.
How can I track Eolo Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Eolo Pharma's shares on secondary markets.